This inventor holds 1 USPTO granted patent. Top assignee: Mor Research Applications Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Avraham Novogrodsky: Innovator in Immuno-stimulatory Monoclonal Antibodies
Introduction
Avraham Novogrodsky is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. His research focuses on developing therapies that enhance the immune response against tumors.
Latest Patents
Avraham holds a patent for immuno-stimulatory monoclonal antibodies. This patent describes a monoclonal antibody that specifically binds to B lymphoblastoid cells, inducing proliferation and activation of peripheral blood lymphocytes. When injected into tumor-bearing animals, this antibody elicits an anti-tumor effect, showcasing its potential in cancer treatment.
Career Highlights
Avraham Novogrodsky is associated with Mor Research Applications Ltd., where he continues to advance his research and development efforts. His work has been instrumental in bridging the gap between laboratory research and practical applications in medicine.
Collaborations
Avraham collaborates with various professionals in his field, including his coworker Britta Hardy. Their combined expertise contributes to the innovative projects at Mor Research Applications Ltd.
Conclusion
Avraham Novogrodsky's contributions to immunology through his patent on monoclonal antibodies highlight his role as a key innovator in the field. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile